Citadel Advisors
ENFN

Citadel Advisors’s Enfusion, Inc. ENFN Stock Holding History

Citadel Advisors’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,037,723
Closed -$10.7M – 15898
2024
Q4 		$10.7M Buy
1,037,723
+564,643
+119% +$5.46M ﹤0.01% 2906
2024
Q3 		$4.49M Buy
473,080
+193,495
+69% +$1.67M ﹤0.01% 4101
2024
Q2 		$2.38M Sell
279,585
-364,579
-57% -$3.34M ﹤0.01% 4993
2024
Q1 		$5.96M Buy
644,164
+520,403
+420% +$4.58M ﹤0.01% 3668
2023
Q4 		$1.2M Sell
123,761
-15,726
-11% -$147K ﹤0.01% 6324
2023
Q3 		$1.25M Buy
139,487
+110,818
+387% +$1.05M ﹤0.01% 6115
2023
Q2 		$322K Sell
28,669
-345,637
-92% -$3.06M ﹤0.01% 8893
2023
Q1 		$3.93M Buy
374,306
+329,912
+743% +$3.64M ﹤0.01% 4195
2022
Q4 		$429K Buy
+44,394
New +$500K ﹤0.01% 8559
2022
Q2 		– Sell
-165,803
Closed -$2.11M – 14327
2022
Q1 		$2.11M Buy
165,803
+108,877
+191% +$1.66M ﹤0.01% 5978
2021
Q4 		$1.19M Buy
+56,926
New +$1.15M ﹤0.01% 7514

Other funds holding ENFN

FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
LECM
Lead Edge Capital Management New York $408M AUM 4.05% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Citadel Advisors's ENFN Position: Q1 2025 in Review

Citadel Advisors sold out of Enfusion, Inc. (ENFN) in Q1 2025, closing a stake of 1,037,723 shares — an estimated $10.7M sold.

Citadel Advisors first reported a position in ENFN in Q4 2021 and held it in 11 quarters. The position peaked at $10.7M in Q4 2024. 132 funds tracked by Wall St. Rank hold ENFN as of Q1 2025.

  • Citadel Advisors reported no remaining Enfusion, Inc. position as of Q1 2025 after selling out during the quarter.
  • Citadel Advisors sold 1,037,723 Enfusion, Inc. shares in Q1 2025, an estimated $10.7M.
  • Citadel Advisors first reported a position in Enfusion, Inc. in Q4 2021 and held it in 11 quarters.
  • Citadel Advisors's Enfusion, Inc. position peaked at $10.7M in Q4 2024.
  • 132 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q1 2025.

Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.